`

GenScript

Biotechnology Research

Specialities :
Gene synthesis
Peptide synthesis
Protein expression
Antibody services
Drug discovery services

+6

revenue-icon Revenue
1B+
funding-icon Total Funding
--
size-icon Size
501 - 1000

Frequently Asked Questions About GenScript

What does Genscript do?+

Founded in 2002 and listed on the Hong Kong Stock Exchange in 2015, GenScript has an established global presence across Greater China, North America, the EU, and Asia Pacific. Today, over 200,000 customers from over 100+ countries and regions worldwide have used GenScripts premier, convenient, and reliable products and services. GenScript has over 6,900 employees globally, with about 10% R&D personnel. In addition, GenScript has a number of leading commercial technologies developed in the fields of synthetic biology, immunotherapy, antibody design, chemical synthesis, and bioinformatics, including more than 300 patents and about 900 patent applications. As of June 30, 2024,...

What are Genscript's specialties? +

Gene synthesis,peptide synthesis,protein expression,antibody services,drug discovery services,industrial synthetic biology products,gene editing,genome editing,gene therapy ,cell therapy,and cancer research

What is Genscript's industry? +

Genscript operates in the Biotechnology research industry.

What is Genscript's revenue? +

Genscript's revenue is 1b+

What is Genscript's company size? +

Genscript has 501 - 1000 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.